Abstract 165P
Background
The increasing number of patients with multiple primary lung cancers (MPLCs) endows a rising challenge for clinical management. The tumor microenvironment (TME) has a critical role in MPLCs but its contribution to cancer onset remains unclear. Further explorations of TME via single cell transcriptomics would allow for discovery of diagnostic biomarkers and potential therapeutic targets for MPLCs, differing from solitary primary lung cancers (SPLCs).
Methods
We profiled 13 tumors and paired paracancerous samples from 5 MPLC and 3 SPLC patients using single-cell RNA sequencing (scRNA-seq). Seurat was used for dimensional reduction, cluster identification and cell type annotation. Myeloid clusters were analyzed for their marker gene expression and tissue distribution. Cell-cell communication was examined using CellChat. Results were validated in scRNA-seq datasets from independent external cohorts (GSE200972 and E-MTAB-6149), including 25 samples from 4 MPLCs and 3 SPLCs.
Results
We classified 79,944 Monocytes/Macrophages (Mo/Mϕ) into 5 clusters based on the expression of FABP4, F13A1, FCN1, LYVE1 and MKI67. Of note, the F13A1+ Mo/Mϕ subset is preferentially enriched in MPLC tumors rather than normal tissues or SPLC tumors. They display a transcriptional profile resembling M2-like Mϕs and SPP1-expressing Mϕs that are pro-tumor and associated with poor prognosis. They also express high levels of anti-inflammatory markers and low levels of pro-inflammatory genes. CellChat analysis revealed a strong interaction between F13A1+ Mo/Mϕ and NK/T cells in MPLCs, but not SPLCs, via SPP1:CD44 and HLA-E:NKG2A axes, both of which have a negative impact on anti-tumor immunity. These findings were further validated in independent datasets.
Conclusions
We identified a previously undescribed F13A1+ Mo/Mϕ subpopulation preferentially enriched in MPLCs. Our data suggest that they could serve as a diagnostic biomarker to distinguish MPLCs from normal tissues and SPLCs. Crosstalk between F13A1+ Mo/Mϕ and immune cells through specific ligand-receptor interactions may contribute to immune suppression during cancer development, which could be a specific druggable target for MPLCs.
Legal entity responsible for the study
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center.
Funding
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen+SZ2020ZD011; Medical Scientific Research Foundation of Guangdong Province, China; Sanming Project of Medicine in Shenzhen (No. SZSM201612097) and Shenzhen Key Medical Discipline Construction fund (No. SZXK075).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
35P - Peripheral immunotype classification for monitoring Soft Tissue Sarcoma patients
Presenter: Jani Sofia Almeida
Session: Poster Display
36P - Expression of germinal center B cell- and Th17 cell-related transcripts are prognostic of soft-tissue sarcoma patient outcomes
Presenter: Giulia Petroni
Session: Poster Display
38P - Machine learning-based pathomics model to predict the infiltration of Treg and prognosis in IDH-wt GBM
Presenter: Shaoli Peng
Session: Poster Display
40P - The role of low avidity tumour-specific CD8+ T cells in immunotherapeutic response to anti-PD-1
Presenter: Doreen Lau
Session: Poster Display
41P - Contrasting drivers of response to immunotherapy across solid tumour types: results from analysis of >2500 cases
Presenter: Danwen Qian
Session: Poster Display
42P - TCCIA: A Comprehensive Resource for Exploring CircRNA in Cancer Immunotherapy
Presenter: Jian-Guo Zhou
Session: Poster Display
43P - Immune and tumor cells expression of VISTA in a panel of cancer indications: A strategy to inform selection of patients treated with anti-VISTA
Presenter: Pierre Launay
Session: Poster Display
44P - Exploratory Analysis of Peripheral Pharmacodynamic (PD) Biomarkers After Sitravatinib (Sitra) and Tislelizumab (TIS) in Advanced Solid Tumors: SAFFRON-103
Presenter: Yi-Long Wu
Session: Poster Display
45P - Protein biomarkers associated with organ-specific immune-related toxicity and response to management identified by proteome analysis of extracellular vesicles from plasma
Presenter: Anders Kverneland
Session: Poster Display